Subjects in the study who took this probiotic while dieting had significantly more weight loss in the first 12
weeks than those in the placebo group who did not.
Not exact matches
By
week 48, participants had a 52 percent increase
in dystrophin - positive muscle fibers and were able to walk 67.3 meters farther
than the
placebo group on the six - minute walk test.
Two
weeks after the rats sustained their injuries, Schwartz's
group found that the number of surviving cells
in the damaged nerves of these rats was three times higher on average
than in rats with similar damage that received a
placebo injection.
By the end of treatment, the odds of experiencing a heavy drinking day
in the
placebo group was five times more
than that of the topiramate
group; and the number of patients who experienced no heavy drinking days on the last four
weeks of treatment
in the topirmate
group was more
than double that of the
placebo group.
In one study, subjects who experienced social rejection and who received acetaminophen every day for three
weeks reported fewer hurt feelings
than the
group who received the
placebo.
After more
than two
weeks, evidence of variation
in vasodilation due to camu camu extract was negative, with even slightly positive responses
in the
placebo group.
The mean weight loss
in women
in the LPR
group was significantly higher
than that
in women
in the
placebo group (P = 0 · 02) after the first 12
weeks, whereas it was similar
in men
in the two
groups (P = 0 · 53).
After 2 to 6
weeks of treatment with 20 g / d of fructo - oligosaccharides or
placebo, symptoms of irritable bowel syndrome improved more
in the
placebo group than in the fructooligosaccharide
group; however, there was no difference between the
groups after con - tinuous treatment for 12
weeks.
The mean total number of drinks consumed during the 12
week trial was lower
in the fluoxetine
group than in the
placebo group (70 v 216, p < 0.03) as was the mean number of days on which alcoholic drinks were consumed during the trial (11 v 20, p < 0.05).